Supporting Families In Coping With Parental Cancer: A Multi-Site Randomized Controlled Trial
2 other identifiers
interventional
400
1 country
1
Brief Summary
The goal of this behavioral research study is to learn about the effect of a parent support intervention on cancer patients' and their family caregivers' mental wellbeing, and family functioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cancer
Started Mar 2027
Longer than P75 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2026
CompletedFirst Posted
Study publicly available on registry
October 1, 2026
CompletedStudy Start
First participant enrolled
March 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2031
Study Completion
Last participant's last visit for all outcomes
September 30, 2033
October 1, 2026
September 1, 2026
4.6 years
September 28, 2026
September 28, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Safety and Adverse Events (AEs)
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Through study completion; an average of 1 year
Study Arms (2)
CTL: Patients Receive Cancer Treatment Per Usual Care (UC) Control Group
EXPERIMENTALINTERV: Parent - Caregiver Dyads TO The Parent Support Intervention
NO INTERVENTIONInterventions
Participants will receive one 60 min. session per week for 6 weeks (4 sessions, 240 min. total).
Eligibility Criteria
You may qualify if:
- Patients:
- Diagnosed with a metastatic (stage IV) breast, thoracic, gastrointestinal, gynecologic, or genitourinary cancer
- With at least one dependent child between the ages of 4 and 17 years and currently living with the parent
- ECOG performance status of ≤ 2122
- With a spousal caregiver/partner who co-parents the child(ren) OR a family caregiver who offers care and support to both the patient and the child(ren) as determined by the patient.
- Patients and Caregivers:
- At least 18 years old;
- Able to read and speak English and/or Spanish.
You may not qualify if:
- Experiences cognitive deficits that would impede the completion of self-report instruments and intervention engagement as deemed by their attending oncologist per medical notes and/or patient not being oriented to time, place and person during the recruitment process
- Regularly (self-defined) participants in individual, couple and/or family psychotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UT MD Anderson
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Kathrin Milbury, MA, PHD
UT MD Anderson
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2026
First Posted
October 1, 2026
Study Start (Estimated)
March 1, 2027
Primary Completion (Estimated)
September 30, 2031
Study Completion (Estimated)
September 30, 2033
Last Updated
October 1, 2026
Record last verified: 2026-09